Community participation needed for “Bras for a Cause”

Translate to Spanish or other 102 languages!

Photo Used for Illustration Purposes. Photo by drazenphoto
- Advertisement -

Every October, DHR Health employees tap into their creativity to participate in the hospital’s annual “Bras for a Cause” fundraiser. This event supports underserved cancer patients throughout the Rio Grande Valley by providing vital resources such as transportation assistance, financial aid, and oncology wigs through the Renaissance Cancer Foundation.

This year, nearly 30 decorated bras were submitted by employees from various departments, showcasing their enthusiasm for raising awareness about breast cancer screenings and mammograms.

“We hold this contest every year as a fun and engaging way for our employees to help promote breast cancer awareness,” said Evelyn Saenz, Executive Director of the Renaissance Cancer Foundation. “We’re always so impressed by the many creative entries we receive.”

- Advertisement -

Community members are encouraged to visit www.dhrhealth.com/brasforacause to view photos of the bra entries and cast their votes by making donations. The bras with the highest donation totals will be declared winners of the fundraiser. Voting is open to the community until October 20, 2024.

All donations to the Renaissance Cancer Foundation are tax-deductible and directly support local cancer patients facing financial challenges during their treatment. For more information about the Renaissance Cancer Foundation or how to get involved, please contact Executive Director Evelyn Saenz at ev.saenz@dhr-rgv.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.

STHS Scores Fourth Consecutive 5-Star Rating for Diabetic Care

Diabetes remains one of the nation’s most pressing health challenges, with a disease once largely associated with older adults now affecting younger populations at an alarming rate.
- Advertisement -